对肺功能测试和在COVID-19后轻度中度病例中的动脉硬性的影响
Ragini Mundhe1, Vidya Ganji2, Veerisetty Neeraja3
1MBBS Final year student, All India Institute of Medical Sciences (AIIMS), Bibinagar, India.
Maedica
|July 18, 2025
概括
定期练习可以显著改善肺功能,并减少从轻度至中度COVID-19中恢复过来的个体的动脉硬. 这项为期八周的干预措施改善了感染后的肺容量和血管健康.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 综合医学是一个整体的医学.
背景情况:
- COVID-19 (由SARS-CoV-2引起) 可以导致长期的呼吸系统问题和内皮损伤,增加动脉硬度.
- 众所周知,是一种整体的练习,有利于心血管和肺功能.
- 这项研究调查了对COVID-19后肺功能和动脉硬性的影响.
研究的目的:
- 为了评估八周干预对肺功能测试的影响.
- 评估对轻度至中度后COVID-19病例的动脉硬性的影响.
主要方法:
- 30名COVID-19后患者接受了为期8周的干预.
- 肺功能测试 (包括FEV1,FEV3,FVC,FEV1/FVC比率) 使用计算机化螺旋计进行评估.
- 使用振荡计法测量动脉硬度,评估脚脉冲波速率 (baPWV) 和大动脉-大腿脉冲波速率 (cfPWV).
主要成果:
- 干预导致FEV1,FEV3,FVC和FEV1/FVC比率在统计学上显著增加 (p<0.05).
- 在baPWV和cfPWV (p<0.001) 中观察到非常显著的下降,表明动脉硬性减少.
- 在缩血压和baPWV (r=0.45,p<0.001) 和cfPWV (r=0.37,p<0.05) 之间发现了正相关性.
结论:
- 八周的定期练习显著改善了COVID-19后患者的肺功能测试.
- 干预有效地减少了从轻度到中度COVID-19中恢复过来的个体的动脉硬.
- 在COVID-19恢复后对血管和动脉硬产生有益影响.
相关概念视频
01:25Pulmonary Function Tests
435
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
435
01:20COPD: Pathogenesis and Clinical Features
529
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
529
01:26COPD: Management Using Bronchodilators and Corticosteroids
315
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
315
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K